Tiverton Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Tiverton Asset Management’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$78K	Hold	10,419	–	–	﹤0.01%	663
2019 Q2	$97K	Hold	10,419	–	–	﹤0.01%	626
2019 Q1	$55K	Sell	10,419 -2,244	-18%	-$12.8K	﹤0.01%	628
2018 Q4	$56K	Buy	+12,663	New	+$69.4K	﹤0.01%	438
2018 Q3	–	Sell	-132,318	Closed	-$929K	–	421
2018 Q2	$929K	Hold	132,318	–	–	0.05%	197
2018 Q1	$1.88M	Hold	132,318	–	–	0.13%	120
2017 Q4	$1.16M	Sell	132,318 -14,754	-10%	-$146K	0.07%	174
2017 Q3	$1.72M	Buy	147,072 +9,340	+7%	+$114K	0.1%	146
2017 Q2	$1.92M	Buy	137,732 +54,560	+66%	+$624K	0.1%	150
2017 Q1	$1.14M	Hold	83,172	–	–	0.06%	164
2016 Q4	$596K	Sell	83,172 -39,964	-32%	-$438K	0.04%	180
2016 Q3	$1.87M	Buy	123,136 +114,524	+1,330%	+$1.51M	0.15%	130
2016 Q2	$760K	Sell	8,612 -280,138	-97%	-$3.84M	0.03%	148
2016 Q1	$3.85M	Buy	+288,750	New	+$3.63M	0.13%	119

Other funds holding SNDX

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Tiverton Asset Management's SNDX Position: Q3 2019 in Review

Tiverton Asset Management held its Syndax Pharmaceuticals (SNDX) position steady in Q3 2019 at 10,419 shares worth $78K. The position accounts for ﹤0.01% of the portfolio, ranked #663.

Tiverton Asset Management first reported a position in SNDX in Q1 2016 and has held it in 14 quarters since. The position peaked at $3.85M in Q1 2016. 72 funds tracked by Wall St. Rank hold SNDX as of Q3 2019.

Tiverton Asset Management held 10,419 shares of Syndax Pharmaceuticals worth $78K as of Q3 2019.
Tiverton Asset Management left its Syndax Pharmaceuticals share count unchanged in Q3 2019.
Syndax Pharmaceuticals made up ﹤0.01% of Tiverton Asset Management's portfolio in Q3 2019, its #663 holding.
Tiverton Asset Management first reported a position in Syndax Pharmaceuticals in Q1 2016 and has held it in 14 quarters since.
Tiverton Asset Management's Syndax Pharmaceuticals position peaked at $3.85M in Q1 2016.
72 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.